Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Active, not recruiting · NCT03543969 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, cutaneous melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin carcinoma, skin disorder, skin neoplasm | Active, not recruiting | Early phase 1 | 2026-02-05 | NCT03543969 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | United States | 32 |